The Spanish Agency for Medicines and Health Products (AEMPS), dependent on the Ministry of Health, has ordered the cessation of marketing and withdrawal from the Autotest Market of Novid antigens of Genrui laboratories, for sale in pharmacies.
The withdrawal of these test reaches after the Irish regulatory authorities (HPRA) detected half a thousand false positives erroneously diagnosed with those devices.
As AEMPS points out, the products affected are the Autotest of Covid antigens of Genrui laboratories with references 52104097 and 52112086.
It is one of the 20 Autotest brands of authorized antigens in Spain and that are available at the pharmacies of our country.
The Spanish Agency for Medicines and Health Products (AEMPS) has initiated an investigation and as a precautionary measure has required distributors of this product in Spain that voluntarily carry out the cessation of marketing and withdrawal from the product market.
